Biochemcial Markers Flashcards

1
Q

What is the prevalence of chromosomal abnormalities in early pregnancy loss?

A

50%

This statistic highlights the significant rate of chromosomal issues contributing to early pregnancy loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What percentage of stillbirths and neonatal deaths is attributed to chromosomal abnormalities?

A

6-11%

These figures indicate the impact of chromosomal anomalies on perinatal mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the prognosis for children with Trisomy 21 in terms of life expectancy?

A

Mean survival 55 years

Children with Trisomy 21 typically experience moderate mental retardation and have a life expectancy that varies significantly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What maternal age is considered for offering prenatal diagnosis?

A

35 years and older

Advanced maternal age is a key factor in assessing the risk of chromosomal abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the indications for prenatal diagnosis.

A
  • Advanced maternal age
  • Parental chromosome rearrangements
  • Previous affected child
  • Positive aneuploidy screening test
  • Abnormal ultrasound findings

These indications help identify pregnancies at higher risk for genetic disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the risk of Trisomy 21 at 35 years of maternal age?

A

1/270

The risk increases with maternal age, making screening essential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What defines an ideal screening test?

A
  • High sensitivity
  • High specificity
  • Positive early in gestation
  • Easy
  • Inexpensive

These characteristics ensure effective and reliable screening outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

True or False: The age limit for offering prenatal screening is based on a biological difference.

A

False

The age limit is more about logistical concerns than biological differences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the detection rate of the second trimester Down Syndrome screening for women younger than 35?

A

60%

This screening is performed between 16-20 weeks and is most accurate between 16-18 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What biochemical markers are used in the second trimester screening for Down Syndrome?

A
  • Maternal age
  • Alpha-fetoprotein (AFP)
  • Beta-hCG (bhCG)
  • Unconjugated Estriol (uE3)

These markers help calculate the risk of Down Syndrome in the fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fill in the blank: The risk of spontaneous fetal death for Trisomy 21 fetuses between 12 weeks and term is _______.

A

30%

This statistic emphasizes the risk associated with Trisomy 21 during pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the risk of cardiac defects associated with Trisomy 21?

A

5-30%

Cardiac anomalies are commonly linked with chromosomal abnormalities.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the detection rates of biochemical markers according to maternal age for Down Syndrome?

A
  • 20 years: 2.4% screen-positive rate, 41% detection rate
  • 35 years: 14% screen-positive rate, 71% detection rate
  • 40 years: 40% screen-positive rate, 91% detection rate

These rates illustrate how detection improves with maternal age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the significance of Nuchal Translucency measurement in prenatal screening?

A

Increased measurement indicates higher risk for aneuploidies

Nuchal translucency is a key marker for assessing risks of chromosomal abnormalities early in pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the fetal death risk associated with Trisomy 18 and Trisomy 13 fetuses between 12 weeks and term?

A

80%

This high rate underscores the severity of these conditions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the effect of maternal age on serum screening detection rates?

A

Both detection rate and screen positive rate increase with maternal age

This relationship is important for risk assessment in prenatal care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

True or False: Ultrasound abnormalities involving a major organ indicate a low risk of aneuploidy.

A

False

Major organ abnormalities are significant markers for higher aneuploidy risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the role of Free beta-hCG in first trimester screening?

A

Consistently elevated between 8-13 weeks

Free beta-hCG is an important marker for assessing risk early in pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are common non-specific sonographic findings in first trimester screening?

A
  • Embryo size
  • Yolk sac size
  • Persistent posterior fossa cysts

These findings can help identify potential issues but are not definitive on their own.

20
Q

What is nuchal translucency (NT)?

A

A measurement used in prenatal screening to assess the risk of chromosomal abnormalities in a fetus.

21
Q

What is the gestational age range for measuring nuchal translucency?

A

11 to 13 weeks (CRL 45-84mm).

22
Q

What is the significance of a maximum NT measurement greater than 6 mm?

A

Indicates a 36x age-related risk for aneuploidy.

23
Q

What is the false positive rate (FPR) for nuchal translucency screening?

A

2.5% to 9.3%.

24
Q

True or False: Nuchal translucency measurements can vary due to differences in techniques.

25
Q

What is the sensitivity for Down syndrome (DS) detection with NT > 3.5 mm?

26
Q

What is the relationship between NT thickness and maternal age regarding aneuploidy risk?

A

Higher NT thickness correlates with increased age-related risk.

27
Q

List some congenital anomalies associated with abnormal nuchal translucency.

A

Down Syndrome, Patau Syndrome, Edward’s Syndrome, Turners Syndrome

  • Obstructive uropathies
  • Noonan syndrome
  • Diaphragmatic hernia
  • Renal anomalies
  • Abdominal wall defect
  • Rare genetic syndromes.
28
Q

What is the role of nasal hypoplasia in prenatal screening?

A

Absent nasal bone is associated with increased risk for Down syndrome.

29
Q

What is the recommended age for offering aneuploidy screening to all women?

A

Before 20 weeks of gestation.

30
Q

What is the purpose of the Integrated Screen in prenatal care?

A

To adjust a woman’s age-related risk of having a child with Down syndrome.

31
Q

What are the two strategies proposed in sequential screening?

A
  • Stepwise sequential screening
  • Contingent sequential screening.
32
Q

How is fetal aneuploidy diagnosed?

A

AMNIOCENTESIS
– Offered between 15 and 20 weeks
– Cytogenic diagnosis accuracy (>99%)
– Fetal loss 0. 5%
– Transient vaginal spotting or leakage 1-2%
– Chorioamnionitis < 1 in 1,000
– Needle injuries to fetus are rare
– AF cell culture failure is uncommon

33
Q

What is the pregnancy loss rate associated with early amniocentesis?

34
Q

What is the fetal loss rate for chorionic villus sampling (CVS)?

35
Q

Fill in the blank: The mean half-life for fetal DNA in maternal circulation is ______.

A

16.3 minutes.

36
Q

What is the detection rate for fetal DNA in Down syndrome cases?

A

21% at a 5% false-positive rate.

37
Q

Who is considered at risk for fetal aneuploidy?

A
  • Women age 35 or older
  • Previous pregnancies with autosomal trisomy
  • Fetus with major structural defect.
38
Q

What is a significant marker for preterm delivery in maternal circulation?

A

Increased levels of fetal DNA.

39
Q

What screening tests are included in the Quad screen?

A
  • AFP
  • uE3
  • hCG
  • Inhibin A.
40
Q

What condition is associated with a five-fold increase in fetal DNA in maternal samples?

A

Preeclampsia.

41
Q

What is the purpose of fetal echo during the second trimester?

A

Recommended if abnormal NT is detected.

42
Q

True or False: The absence of ultrasound evidence for Down syndrome decreases the risk sufficiently to avoid amniocentesis.

43
Q

What is the association between limb reduction and oromandibular defects?

A

The association is not clear.

44
Q

What’s in the Intergrated Screen?

A

Integrated Screen:

1st trimester NT,
PAPP-A,
2nd trimester AFP,
uE3,
hCG,
Inhibin A

45
Q

What’s in the Serum Integrated Screen?

A

• Serum Integrated screen:

1st trimester
PAPP-A, 2nd trimester hCG, uE3, Inhibin
A